GYRE THERAPEUTICS, INC. ($GYRE)
Filing Information
| Accession Number | 0001140361-26-025950 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
33,000
Total Value
$76,950.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jun 9, 2026 | Exercise/Conversion | 3,000 | $0.75 | $2,250.00 | 703,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 9, 2026 | Sale | 3,000 | $6.15 | $18,450.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 10, 2026 | Exercise/Conversion | 5,000 | $0.75 | $3,750.00 | 705,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 10, 2026 | Sale | 5,000 | $6.24 | $31,200.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 18, 2026 | Exercise/Conversion | 3,000 | $0.75 | $2,250.00 | 703,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 18, 2026 | Sale | 3,000 | $6.35 | $19,050.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 9, 2026 | Exercise/Conversion | 3,000 | $0.00 | $0.00 | 835,701 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 10, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 830,701 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 18, 2026 | Exercise/Conversion | 3,000 | $0.00 | $0.00 | 827,701 | Direct | โ | View Details |